Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study led by Minggui Pan, MD, PhD, and Laurel Habel, PhD, suggests ties among mutation type, tumor location, and survival.
Kaiser Permanente study by Joan Lo, MD, and Marilyn Kwan, PhD, suggests studies that follow breast cancer survivors over time should differentiate between fracture types.
The Kaiser Permanente Division of Research postdoctoral research program drew one of its largest-ever classes of fellows this year, building the strength of DOR's research portfolio. Seven fellows cover fields from diet to dementia, cancer to clinical informatics, to women's and children's health, and more.
Kaiser Permanente study shows survey tools routinely used in clinical trials can be successfully integrated into electronic medical records.
New study describes how patients and physicians benefitted when Kaiser Permanente Northern California established a virtual, multidisciplinary gastric cancer team.
Research presented at the American Society for Clinical Oncology annual meeting amplified the ways the Division of Research and The Permanente Medical Group advance cancer care.
Kaiser Permanente research scientist uses her expertise in epidemiology and nutrition to improve outcomes for cancer patients and enhance their survivorship.
Kaiser Permanente study by adjunct investigator and oncologist/hematologist Minggui Pan, MD, PhD, quantifies impact of a virtual tumor board for rare type of cancer.
Kaiser Permanente study, believed to be the first to look at hormone therapy initiation and adherence in this population, suggests lower rates of use may be contributing to higher breast cancer death rates.
People can look to the Northern European side of their genetic heritage for increased risk of nonmelanoma skin cancer, according to the first large analysis of genetic risk factors for cutaneous squamous cell carcinoma in diverse populations with European ancestry from Kaiser Permanente researchers.